Pandorum Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10.6M
- Investors
-
26
Pandorum General Information
Description
Developer of functional human tissues designed for tissue engineering and regenerative medicine. The company's experimental-stage human liver tissue is created using three-dimensional printing technology and acts as an artificial liver during liver failures or liver transplantation and takes less time to regenerate, enabling surgeons to assure painless liver surgeries.
Contact Information
Website
pandorum.comCorporate Office
- EGF 5, Bangalore Bioinnovation Centre
- Bangalore Helix Biotech Park, Electronics City Phase 1
- Bengaluru, Karnataka 560100
- India
Corporate Office
- EGF 5, Bangalore Bioinnovation Centre
- Bangalore Helix Biotech Park, Electronics City Phase 1
- Bengaluru, Karnataka 560100
- India
Pandorum Timeline
Pandorum Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
12. Later Stage VC | 15-Mar-2024 | $10.6M | 000.00 | 000.00 | Completed | Generating Revenue |
11. Accelerator/Incubator | 14-Oct-2022 | 000.00 | Completed | Generating Revenue | ||
10. Later Stage VC | 20-Oct-2021 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
9. Later Stage VC (Series B) | 08-Sep-2020 | 00.000 | 00.00 | 000.00 | Completed | Generating Revenue |
8. Later Stage VC (Series A) | 13-Feb-2018 | 00.000 | 00.000 | 000.00 | Completed | Product Development |
7. Angel (individual) | 24-Dec-2016 | 00000 | 00000 | 00.000 | Completed | Startup |
6. Grant | 01-Jan-2014 | 00000 | Completed | Startup | ||
5. Grant | 01-Jan-2012 | 00000 | 00000 | Completed | Startup | |
4. Angel (individual) | $400K | $450K | Completed | Startup | ||
3. Accelerator/Incubator | $50K | Completed | Startup |
Pandorum Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A2 CCPS | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
Series A1 CCPS | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.00 | |
Ordinary Shares | 000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
Preferance Shares | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
Preferance Shares | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
Preferance Shares | 36,457 | $14.199461 | $72.14 | $72.14 | 1x | $72.14 | 14.14% | |
Ordinary Shares | 8,702 | $0.012064 | $27.72 | $27.72 | 1x | $27.72 | 3.37% |
Pandorum Comparisons
Industry
Financing
Details
Pandorum Competitors (7)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Organovo | Formerly VC-backed | San Diego, CA | 00 | 0000 | 00000000 | 0000 |
Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada | 000 | 000.00 | 0000000000 | 000.00 |
Synthecon | Accelerator/Incubator Backed | Houston, TX | 00 | 0000000000 | ||
Cerapedics | Venture Capital-Backed | Westminster, CO | 000 | 00000 | 000000000 | 00000 |
InSphero | Venture Capital-Backed | Schlieren, Switzerland | 00 | 000.00 | 0000000000 0 | 000.00 |
Pandorum Patents
Pandorum Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4384601-A1 | Methods for culturing mesenchymal stem cells, compositions and implementations thereof | Pending | 11-Aug-2021 | 0000000000 | |
JP-2024530048-A | Methods, compositions and their implementation for culturing mesenchymal stem cells - patents.com | Pending | 11-Aug-2021 | 0000000000 | |
AU-2020320220-A1 | Bioengineered formulation, process for preparing and implementations thereof | Inactive | 26-Jul-2019 | 0000000000 | |
GB-2604239-A | Bioengineered formulation, process for preparing and implementations thereof | Pending | 26-Jul-2019 | 0000000000 | 0 |
GB-202202474-D0 | Bioengineered formulation, process for preparing and implementations thereof | Pending | 26-Jul-2019 | A61F2/142 |
Pandorum Executive Team (5)
Name | Title | Board Seat |
---|---|---|
Tuhin Bhowmick Ph.D | Co-Founder, Chief Executive Officer & Board Member | |
Arun Chandru Ph.D | Co-Founder, Chief Technology Officer & Board Member | |
Phani Karra | Director of Finance | |
Satish Nadig Ph.D | Chief Medical Advisor |
Pandorum Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Arun Chandru Ph.D | Pandorum | Co-Founder, Chief Technology Officer & Board Member | 000 0000 |
Manish Belmannu | Self | Board Member | 000 0000 |
Sailesh Tulshan | 021 Capital | Board Member | 000 0000 |
Sonal Asthana | Self | Board Member | 000 0000 |
Sudipta Gautam | Indian Angel Network | Board Member | 000 0000 |
Pandorum Signals
Pandorum Investors (26)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Acebright | Corporation | Minority | 000 0000 | 000000 0 |
Ashish Kacholia | Angel (individual) | Minority | 000 0000 | 000000 0 |
Bandana Kankani | Angel (individual) | Minority | 000 0000 | 000000 0 |
Equipact Advisory | Venture Capital | Minority | 000 0000 | 000000 0 |
Everest Finance and Investment | Venture Capital | Minority | 000 0000 | 000000 0 |
Pandorum FAQs
-
When was Pandorum founded?
Pandorum was founded in 2009.
-
Who is the founder of Pandorum?
Tuhin Bhowmick Ph.D and Arun Chandru Ph.D are the founders of Pandorum.
-
Who is the CEO of Pandorum?
Tuhin Bhowmick Ph.D is the CEO of Pandorum.
-
Where is Pandorum headquartered?
Pandorum is headquartered in Bengaluru, India.
-
What is the size of Pandorum?
Pandorum has 37 total employees.
-
What industry is Pandorum in?
Pandorum’s primary industry is Biotechnology.
-
Is Pandorum a private or public company?
Pandorum is a Private company.
-
What is the current valuation of Pandorum?
The current valuation of Pandorum is 000.00.
-
What is Pandorum’s current revenue?
The current revenue for Pandorum is 00000.
-
How much funding has Pandorum raised over time?
Pandorum has raised $25.7M.
-
Who are Pandorum’s investors?
Acebright, Ashish Kacholia, Bandana Kankani, Equipact Advisory, and Everest Finance and Investment are 5 of 26 investors who have invested in Pandorum.
-
Who are Pandorum’s competitors?
Organovo, Aspect Biosystems, Synthecon, Cerapedics, and InSphero are some of the 7 competitors of Pandorum.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »